Inmune Bio Files 8-K Report

Ticker: INMB · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1711754

Inmune Bio, Inc. 8-K Filing Summary
FieldDetail
CompanyInmune Bio, Inc. (INMB)
Form Type8-K
Filed DateApr 1, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, reporting, corporate-filing

Related Tickers: INMB

TL;DR

INMB filed an 8-K, mostly routine stuff, no major news.

AI Summary

On April 1, 2025, Inmune Bio, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific material events detailed in the provided text. The company is incorporated in Nevada and its principal executive offices are located in Boca Raton, Florida.

Why It Matters

This filing indicates routine corporate reporting by Inmune Bio, Inc. to the SEC, which is standard practice for publicly traded companies.

Risk Assessment

Risk Level: low — The filing appears to be a routine 8-K with no immediate indication of significant new risks or material adverse events.

Key Players & Entities

  • Inmune Bio, Inc. (company) — Registrant
  • April 1, 2025 (date) — Date of earliest event reported
  • Nevada (jurisdiction) — State of incorporation
  • Boca Raton, Florida (location) — Address of Principal Executive Offices

FAQ

What is the primary purpose of this 8-K filing for Inmune Bio, Inc.?

The filing is a Current Report on Form 8-K, primarily covering 'Other Events' and 'Financial Statements and Exhibits'.

When was the earliest event reported in this filing?

The earliest event reported was on April 1, 2025.

In which state is Inmune Bio, Inc. incorporated?

Inmune Bio, Inc. is incorporated in Nevada.

What is the address of Inmune Bio, Inc.'s Principal Executive Offices?

The address is 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432.

What is the company's telephone number?

The company's telephone number is (858) 964-3720.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Inmune Bio, Inc. (INMB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.